We develop statistical methods to improve our understanding of tumor cell-to-cell variability and its relationship to cancer progression.
Browse Cancer Center Research Labs
Research in the Bar-Peled laboratory sits at the interface of cellular metabolism and signal transduction and focuses on understanding how cancer cells respond to altered metabolic states.
The Nabeel M. Bardeesy, PhD Laboratory focuses on defining the pathways driving the pathogenesis of pancreatic and biliary cancers.
The Benes laboratory, known as The Center for Molecular Therapeutics, is engaged in the design and application of personalized therapies for cancer. Research topics include: the response to cancer therapeutics, the molecular basis of sensitivity to specific drugs and how to identify the genetic variations affecting the response to targeted therapies.
A major focus of the Bernstein Lab is to understand how epigenetic lesions conspire with genetic events to drive tumorigenesis and drug resistance.
The lab is designed to provide a collaborative resource that can provide expertise and services on tissue acquisition, preparation, specialized histological stains, and high-end digital microscopy quantitative analysis.
The Division of Biostatistics & Biomathematics supports research-oriented databases and data management needs for Radiation Oncology.
The Boland Lab at Massachusetts General Hospital focuses on blood-based techniques for assessing changes in the tumor microenvironment through analysis of circulating exosomes.
The Brastianos laboratory studies genomic drivers of human brain tumors.
The Cancer Outcomes Research and Education Program (CORE) conducts innovative research and educational programs to improve the experience and outcomes of patients and caregivers across the continuum of cancer care.